For the biomarkers established in routine diagnostics (CRP, HS-CRP, PCT), the optimized cut-offs resulted in moderate diagnostic power to discriminate between patients with isolated cardiac device pocket infections and healthy controls. This evidence concerns the gene CRP and infection.